Here, we extend our previous findings of EpCAM mRNA and EpCAM protein levels in GCT of different histologies [17] and demonstrate profound in vitro vulnerability of various EpCAM-positive GCT cell lines to the cytotoxic effects of an EpCAM/CD3-bispecific antibody in the presence of immune cells. The gene discussed is EPCAM; the disease is granular cell tumor.